EA201291461A1 - Состав, содержащий лантибиотик типа b - Google Patents

Состав, содержащий лантибиотик типа b

Info

Publication number
EA201291461A1
EA201291461A1 EA201291461A EA201291461A EA201291461A1 EA 201291461 A1 EA201291461 A1 EA 201291461A1 EA 201291461 A EA201291461 A EA 201291461A EA 201291461 A EA201291461 A EA 201291461A EA 201291461 A1 EA201291461 A1 EA 201291461A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lantibiotic
type
composition containing
lantibiotic type
capsule
Prior art date
Application number
EA201291461A
Other languages
English (en)
Inventor
Энтони Николас Апплеярд
Сьёрд Николаас Вадман
Original Assignee
Новакта Биосистемс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новакта Биосистемс Лимитед filed Critical Новакта Биосистемс Лимитед
Publication of EA201291461A1 publication Critical patent/EA201291461A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Описан фармацевтический состав капсулы для пероральной доставки лантибиотика типа В в желудок, содержащий твердую желатиновую, гидроксипропилметилцеллюлозную (ГПМЦ) или крахмальную капсулу и лантибиотик типа В формулы (I)где X представляет собой -NH(CH)NH, a q представляет собой целое число от 2 до 12.
EA201291461A 2010-07-14 2011-07-12 Состав, содержащий лантибиотик типа b EA201291461A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36408810P 2010-07-14 2010-07-14
PCT/GB2011/001046 WO2012007711A1 (en) 2010-07-14 2011-07-12 Formulation comprising a type b lantibiotic

Publications (1)

Publication Number Publication Date
EA201291461A1 true EA201291461A1 (ru) 2013-08-30

Family

ID=44629328

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201291461A EA201291461A1 (ru) 2010-07-14 2011-07-12 Состав, содержащий лантибиотик типа b

Country Status (8)

Country Link
US (1) US20130171252A1 (ru)
EP (1) EP2627320A1 (ru)
JP (1) JP2013531026A (ru)
CN (1) CN103052383A (ru)
CA (1) CA2804697A1 (ru)
EA (1) EA201291461A1 (ru)
MX (1) MX2013000350A (ru)
WO (1) WO2012007711A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
GB201213434D0 (en) * 2012-07-27 2012-09-12 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
US11779302B2 (en) 2018-10-20 2023-10-10 Massachusetts Institute Of Technology Methods and apparatus for imaging with conformable ultrasound patch

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304540A (en) 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5985823A (en) 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
GB0600928D0 (en) * 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
CA2667167C (en) 2006-10-27 2014-02-18 Pfizer Products Inc. Hydroxypropyl methyl cellulose hard capsules and process of manufacture
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity

Also Published As

Publication number Publication date
EP2627320A1 (en) 2013-08-21
CA2804697A1 (en) 2012-01-19
WO2012007711A1 (en) 2012-01-19
US20130171252A1 (en) 2013-07-04
JP2013531026A (ja) 2013-08-01
MX2013000350A (es) 2013-03-18
CN103052383A (zh) 2013-04-17

Similar Documents

Publication Publication Date Title
RU2019131148A (ru) Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
EA200600322A1 (ru) β-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
CY1117330T1 (el) Βενζοδιοξινυλ υποκατεστημενα παραγωγα ινδαζολιου
EA201300200A1 (ru) N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
UA90786C2 (ru) Производные бензамидов и гетероаренов
EA201490477A1 (ru) Фармацевтические составы, содержащие пропиленгликоль-гидрат дапаглифлозина
EA201000050A1 (ru) Замещенные бициклолактамные соединения
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
EA201190320A1 (ru) Гетероциклические сульфонамиды, их применения и фармацевтические композиции
EA200870599A1 (ru) Стабильные препараты лаквинимода
UA110207C2 (en) Pharmaceutical pill that contains 1- (-d- hlyukopiranozyl) -4-methyl -3- [5- (4-fluorophenyl) -2 inhibitors tiyenilmetyl benzol natriydependent transporter of glucose (nzph)
EA201391018A1 (ru) Препараты иммуносупрессантов
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA201270216A1 (ru) Фармацевтический состав
EA201190125A1 (ru) Таблетки для комбинированной терапии
EP3725801A3 (en) Amino diacids containing peptide modifiers
EA201170441A1 (ru) Терапевтические противовирусные пептиды
UA98757C2 (ru) Бензамидные соединения, полезные как ингибиторы деацетилазы гистонов
RU2017102513A (ru) Соль гетероциклического соединения, замещенного галогеном
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
MX345544B (es) Derivados de triazol como ligandos para receptores de acido gamma-aminobutirico (gaba).
EA201290659A1 (ru) Новая композиция ретигабина